Review of guidelines for good practice in decision-analytic modelling in health technology assessment

Abstract

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the publi...

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis

“…The included economic evaluations were critically appraised using a checklist based upon those proposed by Drummond et al, 91 Philips et al 92 and the NICE reference case.…”

Use of evidence in economic decision models: practical issues and methodological challenges

“…These were recently reviewed by Philips et al (2004) who concluded that whilst the guidelines all provided consistent advice regarding some aspects of modelling (e.g. the need to be explicit in presenting an analysis), they offered conflicting guidance on other aspects (e.g.…”

“…Unlike other areas of HTA (e.g. meta-analysis for which the QUOROM statement provides guidance, Moher et al, 1994), there is currently no recommended checklist to assess the quality of published decision models, although the aforementioned review (Philips et al, 2004) did attempt to compile synthesised guidelines and a checklist to provide a framework for critical appraisal of decision models by all parties involved in HTA.…”

Screening for type 2 diabetes: literature review and economic modelling

“…129 The economic models included in the review were appraised by the same reviewer using a published checklist for good practice in decision analytic modelling in health technology assessment. 130 Economic models assessing longterm costs and/or consequences of screening for type 2 diabetes…”